News

  • 4 December 2017

    Xynomic Pharma to start Phase I/II trial for lymphoma

    US-based oncology drug development company Xynomic Pharma is set to begin a Phase I/II trial that will see the combination of Abexinostat with Ibrutinib to treat relapsed/refractory diffuse large b-cell...

  • 1 December 2017

    NIH initiates Phase IIb trial to prevent HIV in Africa

    The National Institutes of Health (NIH) and partners have initiated the proof-of-concept Phase IIb Imbokodo clinical trial in sub-Saharan Africa to assess a new experimental vaccine regimen for the prevention...